Here are three things to know:
1. Spinal Elements received FDA clearance in November for its Ti-Bond surface coating technology. The company’s portfolio includes a number of products featuring Ti-Bond, such as the Lucent XP height- and lordosis-expandable interbody device.
2. The company’s Clutch interspinous process device features a proprietary spring-activated mechanism designed to maintain active compression against the spinous processes to resist loosening and migration.
3. Jason Blain is a founder, president and CEO of Spinal Elements. Mr. Blain has nearly 20 years of experience in orthopedics.
More articles on devices:
ZygoFix begins human clinical trial of spinal facet joint fixation system: 4 things to know
What Morgan Stanley thinks of Smith & Nephew’s new CEO: 5 things to know
Moody’s report shows positive outlook for US medical device sector in 2019 — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
